Cromolyn sodium and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Cromolyn sodium (cromolyn sodium), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Gabapentin, and have Epilepsy.

The phase IV clinical study analyzes which people have Weakness when taking Cromolyn sodium. It is created by eHealthMe based on reports of 2,980 people who have side effects when taking Cromolyn sodium from the FDA, and is updated regularly.

What is Cromolyn sodium?

Cromolyn sodium has active ingredients of cromolyn sodium. It is often used in asthma. eHealthMe is studying from 3,022 Cromolyn sodium users. Check the latest studies of Cromolyn sodium.

What is Weakness?

Weakness is found to be associated with 3,638 drugs and 6,617 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

2,980 people reported to have side effects when taking Cromolyn sodium.
Among them, 88 people (2.95%) have Weakness.

Among these 88 people:

How long have people been on Cromolyn sodium when they have Weakness? *

What is the gender of people who have Weakness when taking Cromolyn sodium? *

female: 77.01 %
male: 22.99 %

What is the age of people who have Weakness when taking Cromolyn sodium? *

What are other drugs people take besides Cromolyn sodium? *

What are other side effects people have besides Weakness? *

Fatigue (feeling of tiredness): 37 people, 42.05%
High Blood Pressure: 22 people, 25.00%
Rashes (redness): 20 people, 22.73%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 19 people, 21.59%
Pneumonia: 18 people, 20.45%
Joint Pain: 18 people, 20.45%
Dry Eyes (lack of adequate tears): 17 people, 19.32%
Dizziness: 16 people, 18.18%
Nausea (feeling of having an urge to vomit): 16 people, 18.18%
Muscle Spasms (muscle contraction): 16 people, 18.18%

What are the existing conditions these people have? *

Depression: 15 people, 17.05%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 15 people, 17.05%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 14 people, 15.91%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 12 people, 13.64%
Hypersensitivity: 6 people, 6.82%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 5.68%
Hereditary Angioedema (recurrent episodes of severe swelling): 5 people, 5.68%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 5.68%
Pain: 4 people, 4.55%
Infection: 4 people, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Cromolyn sodium and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cromolyn sodium:

Cromolyn sodium (3,022 reports)

Weakness treatments and more:

Weakness (586,877 reports)

Browse all side effects of Cromolyn sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,638 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,617 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cromolyn sodium (the active ingredients of Cromolyn sodium) and Cromolyn sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.